Fresenius Medical Care AG (ETR:FME – Get Free Report) shares crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of €45.71 ($53.15) and traded as high as €47.86 ($55.65). Fresenius Medical Care shares last traded at €47.00 ($54.65), with a volume of 395,337 shares trading hands.
Fresenius Medical Care Stock Performance
The company has a market cap of $13.61 billion, a P/E ratio of 20.66, a PEG ratio of 0.42 and a beta of 0.86. The firm has a 50 day moving average of €43.51 and a 200-day moving average of €45.71. The company has a quick ratio of 0.80, a current ratio of 1.37 and a debt-to-equity ratio of 82.24.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Further Reading
- Five stocks we like better than Fresenius Medical Care
- Basic Materials Stocks Investing
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- What is a Bond Market Holiday? How to Invest and Trade
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- What is a Special Dividend?
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.
